Bottom line
What is BRCAX's expense ratio?
BRCAX's expense ratio is 1.49%, or about $149 a year on every $10,000 invested. That is more expensive than 81% of commodities funds we track (median 0.9%). This share class also charges a front-end sales load of up to 5.5%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Mar 12, 2026
BRCAX fee table
| Net expense ratio | 1.49% |
|---|---|
| Gross expense ratio | 1.55% |
| Management fee | 0.85% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.36% |
| Acquired fund fees | 0.09% |
| Fee waiver / reimbursement | -0.06% |
| Max front-end sales load | 5.5% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Mar 12, 2026
What BRCAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| BRCAX | $693 | $1,007 | $1,343 | $2,289 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.49% expense ratio costs roughly $79,100 in lost growth, versus about $50,300 for the median commodities fund (0.9%).